Using a combination of science and innovative AI technology, we aim to make a difference in the lives of patients with neurological disorders." title="" class="btn" data-container="body" data-html="true" data-id="84226" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Combinostics"> 124 1,977
Activities
Technologies
Entity types
Location
Hatanpään valtatie 24, 33100 Tampere, Finland
Tampere
Finland
Employees
Scale: 11-50
Estimated: 13
Engaged catalyst
2Added in Motherbase
5 years, 3 months agoUsing a combination of science and AI technology, we aim to improve the lives of patients with neurological disorders.
The Combinostics cNeuroTM platform combines the company’s innovative AI technology with a holistic view of patient data (imaging biomarkers, demographic and clinical data, neuropsychology test results, and other biomarkers) to enable clinicians to make reliable, evidence-based diagnostic and management decisions for their patients with neurological disorders.
Clinical Decision Support, Medical Imaging, and Alzheimer's disease
Using a combination of science and innovative AI technology, we aim to make a difference in the lives of patients with neurological disorders.
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 13 Oct 2022 | | |
![]() Nokia Telecoms, Telecommunications | Nokia Telecoms, Telecommunications | Other 21 Nov 2019 | |